Association of high γ′ fibrinogen levels with adverse events in patients with COVID-19
Saved in:
Main Authors: | Queen Revollido, Lydia Buzzard, David X. Lee, Matthew Strnad, Scott McLoud, Akram Khan, William B. Messer, David H. Farrell |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2025-02-01
|
Series: | Blood Vessels, Thrombosis & Hemostasis |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2950327225000051 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Disproportionality analysis of upadacitinib-related adverse events in inflammatory bowel disease using the FDA adverse event reporting system
by: Shiyi Wang, et al.
Published: (2025-02-01) -
Efficacy and fibrinogen correlations of defibrinogen therapy in idiopathic sudden sensorineural hearing loss
by: Bing Wang, et al.
Published: (2025-02-01) -
Adverse events in the nervous system associated with blinatumomab: a real-world study
by: Wen Gao, et al.
Published: (2025-02-01) -
Comparisons of adverse events associated with immune checkpoint inhibitors in the treatment of non-small cell lung cancer: a real-world disproportionality analysis based on the FDA adverse event reporting system
by: Ruichen Gao, et al.
Published: (2025-02-01) -
Expanding on Abraxane Safety: Temporal Insights and Future Directions for Adverse Event Analysis [Letter]
by: Yang F, et al.
Published: (2025-02-01)